Pilot Grant Analysis Examines Prior Authorization Trends for MOUD in Private Insurance
There is a growing body of research illustrating a movement to remove prior authorization for medications for opioid use disorder (MOUD). Prior authorization requires providers to request approval from an insurer before providing a medication or service. This process is historically enforced for a wide range of medications, including certain MOUD, and has been found […]
Improving Substance Use Treatment Access in Criminal-legal Systems through JCOIN 2.0
On September 29, 2025, the Justice Community Overdose Innovation Network (JCOIN) kicked off Phase II of its new five-year cycle that represents an estimated $33 million in research investments in 2025. Awarded by the National Institute on Drug Abuse (NIDA) as part of the NIH HEAL Initiative, the investments help establish clinical research hubs and […]
Understanding the Costs of Using Implementation Facilitation to Implement Emergency Department-Initiated Buprenorphine
Buprenorphine, when prescribed in the emergency department (ED), increases the chances for treatment engagement and retention among patients with opioid use disorder (OUD). The patient uptake and clinical administration of ED-initiated buprenorphine for OUD, however, has been slow despite evidence of its effectiveness. Implementation facilitation (IF), a strategy that leverages external facilitators and a local […]
Engage with CHERISH
Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.